Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System

Core Insights - The manufacturing line for the Pivot Controller has been validated for human-use production, supporting an expected market launch in Q1 2026 [1] - Pivot aims to introduce the first two-part tubeless patch pump, targeting the $3 billion market for adult "almost-pumpers" with a design that is affordable, user-friendly, and easy to learn [1]